机器人辅助骶骨阴道固定术中不同充气压力下的疼痛:一项随机对照试验
本单盲随机试验将80例子宫脱垂行机器人辅助骶骨阴道固定术的女性分为12 mmHg实验组(41例)与15 mmHg标准组(39例),实验组术后第1天疼痛视觉模拟评分中位数17.0 mm低于标准组29.0 mm(P=.007),住院及门诊阿片类药物使用更少,手术时间、估计失血量及住院时间无差异。
要点
- 12 mmHg充气压力组术后第1天VAS疼痛中位数17.0 mm,低于15 mmHg组的29.0 mm(P=.007)。
- 实验组住院期间(P=.04)及门诊(P=.02)阿片类药物使用均少于标准组。
- 手术时间、估计失血量及住院时间在两组间无差异。
核心结论
- 与标准压力15 mmHg相比,机器人辅助骶骨阴道固定术中采用较低充气压力12 mmHg可安全减少术后疼痛和阿片类药物使用。
研究设计与样本
- 单盲随机对照试验,纳入80例子宫脱垂行机器人辅助骶骨阴道固定术的女性,实验组41例采用12 mmHg充气压力,标准组39例采用15 mmHg。
- 主要结局为术后第1天(术后24小时内)视觉模拟评分(VAS)疼痛评分;次要结局包括门诊随访时VAS疼痛评分、住院及门诊阿片类药物使用、手术时间和估计失血量。
- VAS临床差异界值为15 mm,在80%把握度下至少需要64例参与者以达到显著性。
- 研究时间为2021年4月27日至2022年5月17日,所有参与者按计划手术并完成术后2周随访。
主要发现
- 实验组术后第1天疼痛VAS中位数17.0 mm(四分位距26.0),标准组为29.0 mm(四分位距32.0),P=.007。
- 实验组住院期间阿片类药物使用较少(P=.04),门诊阿片类药物使用也较少(P=.02)。
- 手术时间、估计失血量及住院时间等次要结局两组间无差异。
- 多变量分析中,较低充气压力和较大年龄与术后VAS评分呈负相关。
临床怎么用
- 作者结论认为,机器人辅助骶骨阴道固定术中采用较低充气压力12 mmHg相比标准压力15 mmHg可安全减少术后疼痛和阿片类药物使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether decreasing insufflation pressure reduces postoperative pain and opioid use in women undergoing robotic-assisted sacrocolpopexy. METHODS: In a single-blinded randomized trial, women with pelvic organ prolapse underwent robotic-assisted sacrocolpopexy at either 12 mm Hg (experimental) or 15 mm Hg (standard) insufflation pressure. The primary outcome was pain rating on a visual analog scale (VAS) on postoperative day 1 within 24 hours of surgery. Secondary outcomes included VAS pain rating at outpatient follow-up, inpatient and outpatient use of opioids, operative time, and estimated blood loss. A margin of 15 mm was considered clinically different on the VAS, and at 80% power, a sample size of at least 64 participants was needed to show significance. RESULTS: From April 27, 2021, to May 17, 2022, 80 women were enrolled, with 41 in the experimental group and 39 in the standard group. All participants underwent surgery as planned and attended a 2-week postoperative follow-up. Participants in the experimental group had less pain on postoperative day 1 with median VAS of 17.0 mm (interquartile range 26.0) compared with 29.0 mm (interquartile range 32.0, P=.007) in the standard group. No differences were noted in the secondary outcomes of operative time, estimated blood loss, or length of stay. Participants in the experimental group were noted to use fewer opioids while an inpatient (P=.04) and outpatient (P=.02). In multivariable analyses, lower insufflation pressure and increasing age were negatively associated with postoperative VAS scores. CONCLUSION: Lowering insufflation pressure (12 mm Hg) during robotic-assisted sacrocolpopexy safely reduced postoperative pain and opioid use compared with standard pressure (15 mm Hg). CLINICAL TRIAL REGISTRATION: ClinialTrials.gov, NCT04858438.
引用
- Rustia GM, Baracy MG, Khair E, et al. Pain With Differing Insufflation Pressures During Robotic Sacrocolpopexy: A Randomized Controlled Trial. Obstet Gynecol. 2023. PMID: 37348093. doi:10.1097/AOG.0000000000005231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。